StonvexLoading…
StonvexStonvexStonvexCore line items from AMBA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $390.70M | $284.87M | $226.47M | $337.61M |
Operating Income | $-82.53M | $-126.59M | $-154.56M | $-74.26M |
Net Income | $-75.86M | $-117.13M | $-169.42M | $-65.39M |
EPS (Diluted) | $-1.78 | $-2.84 | $-4.25 | $-1.70 |
Total Assets | $798.60M | $688.97M | $657.65M | $710.20M |
Total Liabilities | $203.81M | $127.56M | $97.78M | $104.11M |
Cash & Equivalents | $191.02M | $144.62M | $144.91M | $113.54M |
Free Cash Flow OCF − CapEx | $58.01M | $23.45M | $7.05M | $29.04M |
Shares Outstanding | 43.31M | 41.96M | 40.52M | 39.04M |